![Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice. - Abstract - Europe PMC Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3454520/bin/nihms398192f5.jpg)
Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice. - Abstract - Europe PMC
![Prostate‐specific antigen: Current status - Brawer - 1999 - CA: A Cancer Journal for Clinicians - Wiley Online Library Prostate‐specific antigen: Current status - Brawer - 1999 - CA: A Cancer Journal for Clinicians - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/6c7e7530-c8b6-4df6-8283-ff36519db3a2/mtbl010.jpg)
Prostate‐specific antigen: Current status - Brawer - 1999 - CA: A Cancer Journal for Clinicians - Wiley Online Library
![Quantifying Differences in Heritability among Psoriatic Arthritis (PsA), Cutaneous Psoriasis (PsC) and Psoriasis vulgaris (PsV) | Scientific Reports Quantifying Differences in Heritability among Psoriatic Arthritis (PsA), Cutaneous Psoriasis (PsC) and Psoriasis vulgaris (PsV) | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-61981-5/MediaObjects/41598_2020_61981_Fig1_HTML.png)
Quantifying Differences in Heritability among Psoriatic Arthritis (PsA), Cutaneous Psoriasis (PsC) and Psoriasis vulgaris (PsV) | Scientific Reports
![Very late local recurrence after surgery for prostate cancer unaccompanied by detectable PSA levels | Prostate Cancer and Prostatic Diseases Very late local recurrence after surgery for prostate cancer unaccompanied by detectable PSA levels | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.pcan.4500861/MediaObjects/41391_2006_Article_BF4500861_Fig1_HTML.jpg)
Very late local recurrence after surgery for prostate cancer unaccompanied by detectable PSA levels | Prostate Cancer and Prostatic Diseases
![Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.350.issue-22/nejmoa031918/production/images/img_medium/nejmoa031918_t2.jpeg)
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM
![PSA guidance for primary care relating to follow - up after diagnosis of prostate cancer - General Practice notebook PSA guidance for primary care relating to follow - up after diagnosis of prostate cancer - General Practice notebook](https://gpnotebook.com/resources/PSAfollowup.png)
PSA guidance for primary care relating to follow - up after diagnosis of prostate cancer - General Practice notebook
![Incorporating Genetic Determinants of Prostate-Specific Antigen Levels Improves Prostate Cancer Screening | medRxiv Incorporating Genetic Determinants of Prostate-Specific Antigen Levels Improves Prostate Cancer Screening | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2022/04/21/2022.04.18.22273850/F4.large.jpg)
Incorporating Genetic Determinants of Prostate-Specific Antigen Levels Improves Prostate Cancer Screening | medRxiv
![Diagnostics | Free Full-Text | Concordance between Response Assessment Using Prostate-Specific Membrane Antigen PET and Serum Prostate-Specific Antigen Levels after Systemic Treatment in Patients with Metastatic Castration Resistant Prostate Cancer: A ... Diagnostics | Free Full-Text | Concordance between Response Assessment Using Prostate-Specific Membrane Antigen PET and Serum Prostate-Specific Antigen Levels after Systemic Treatment in Patients with Metastatic Castration Resistant Prostate Cancer: A ...](https://www.mdpi.com/diagnostics/diagnostics-11-00663/article_deploy/html/images/diagnostics-11-00663-g006-550.jpg)
Diagnostics | Free Full-Text | Concordance between Response Assessment Using Prostate-Specific Membrane Antigen PET and Serum Prostate-Specific Antigen Levels after Systemic Treatment in Patients with Metastatic Castration Resistant Prostate Cancer: A ...
Ethnicity Is an Independent Determinant of Age-Specific PSA Level: Findings from a Multiethnic Asian Setting | PLOS ONE
![Single Subject Studies in Prostate Cancer: How graphing PSA test results and testosterone levels using Process Behavior and Celeration Charts can provide insight and guide clinical decisions Single Subject Studies in Prostate Cancer: How graphing PSA test results and testosterone levels using Process Behavior and Celeration Charts can provide insight and guide clinical decisions](https://www.oncogen.org/userfiles/images/101.png)
Single Subject Studies in Prostate Cancer: How graphing PSA test results and testosterone levels using Process Behavior and Celeration Charts can provide insight and guide clinical decisions
![Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2015.65.34.issue-23/jco.2016.66.7527/20161107/images/medium/jco667527t4.gif)
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value | PLOS ONE
Stacy Loeb, MD on Twitter: "PSA decreased below the threshold for biopsy in 46% of men who made lifestyle changes (no spicy food, alcohol, caffeine or cycling for >8 weeks) before repeat
![Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/12aed22c0affb1decf9e7953f12f3a9fb0849553/22-Table2-1.png)
Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar
Correlation between first, second, third PSA values and PSAV; Spearman... | Download Scientific Diagram
![Pretreatment Predictors of Time to Cancer Specific Death After Prostate Specific Antigen Failure | Journal of Urology Pretreatment Predictors of Time to Cancer Specific Death After Prostate Specific Antigen Failure | Journal of Urology](https://www.auajournals.org/cms/asset/fffb6d08-5996-4454-9b22-de5c6cbe2190/si2.gif)
Pretreatment Predictors of Time to Cancer Specific Death After Prostate Specific Antigen Failure | Journal of Urology
![Cancers | Free Full-Text | Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction Cancers | Free Full-Text | Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction](https://www.mdpi.com/cancers/cancers-13-03381/article_deploy/html/images/cancers-13-03381-g001.png)